Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women

NCT ID: NCT01637727

Last Updated: 2012-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

324 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary goal of this proposed research deals with estimating the risk of developing type 2 diabetes and metabolic syndrome in women with a history of GDM compared to women without a history of GDM. In addition, this study will attempt to evaluate the effect of parity on the late appearance of type 2 diabetes and metabolic syndrome in this unique population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Mellitus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Long term effects of gestational diabetes mellitus in a population of parous women Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GDM1

The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010. Women with a GDM history will be identified based on the gestational diabetes clinic files. Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records.

No interventions assigned to this group

GDM

The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010. Women with a GDM history will be identified based on the gestational diabetes clinic files. Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010.
* Women with a GDM history will be identified based on the gestational diabetes clinic files.
* Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records

Exclusion Criteria

* women who are diagnosed with metabolic syndrome before pregnancy or have type 1 or type 2 diabetes, and
* women with severe chronic diseases.
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arnon Samueloff, Prof

Role: PRINCIPAL_INVESTIGATOR

Shaare Zedek Medical Center

Sorina Grissaro Granovsky, Dr

Role: STUDY_CHAIR

Shaare Zedek Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shaare Zedek Medical Center

Jerusalem, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SORINA GRISARO GRANOVSKY, DR

Role: CONTACT

Phone: 054-4385480

Email: [email protected]

ORIT LAMM, MD

Role: CONTACT

Phone: 02-9934425

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GDM.CTIL

Identifier Type: -

Identifier Source: secondary_id

GDMLTE.10

Identifier Type: -

Identifier Source: secondary_id

GDM.CTIL

Identifier Type: -

Identifier Source: org_study_id